Hereditary angioedema is characterised by unpredictable, painful and potentially life-threatening oedema. Recently, some C1 inhibitors have been approved for self-administration and/or routine prevention, enabling patients to be proactive in managing their disease and reducing the burden of illness. This article discusses the effect of these advances from a specialist nurse’s perspective.
Available from: http://journals.rcni.com/doi/abs/10.7748/ns2013.05.27.37.35.e7336?journalCode=ns